SYNGENE — Syngene International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Syngene International, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,817	13,561	10,767	13,975	13,195
Net Total Accounts Receivable
Net Total Receivables	6,324	6,592	5,580	6,553	5,088
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	22,059	24,253	19,590	22,873	21,428
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26,881	27,772	36,175	40,032	39,703
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	55,638	58,310	61,516	67,959	70,547
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,289	11,882	11,442	13,964	15,523
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	22,662	22,130	18,938	20,691	22,156
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	32,976	36,180	42,578	47,268	48,391
Total Liabilities & Shareholders' Equity	55,638	58,310	61,516	67,959	70,547
Total Common Shares Outstanding